Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Saliva-based COVID-19 DNA Aptamer Test: Formative Usability and Internal Validation Study

NCT04974203 is registered in ClinicalTrials.gov with Achiko AG as lead sponsor.

NCT NCT04974203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04974203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Saliva-based COVID-19 DNA Aptamer Test: Formative Usability and Internal Validation Study
Lead sponsor
Achiko AG
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2021
Completion date
August 31, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19